Arrowhead Pharmaceuticals Reports Positive Cardiometabolic Data at EAS 2026
Arrowhead Pharmaceuticals Unveils Encouraging Clinical Cardiometabolic Findings at the 94th European Atherosclerosis Society Congress Arrowhead Pharmaceuticals has presented new clinical findings supporting the broader use of plozasiran, its investigational small…
Hologic Showcases New ASCO 2026 Data on Breast Cancer Index® and Endocrine Therapy Decisions
Hologic Showcases New ASCO 2026 Data Highlighting the Role of the Breast Cancer Index® Test in Guiding Extended Endocrine Therapy Decisions Hologic and its subsidiary Biotheranostics have announced new clinical…
LIB Therapeutics Highlights LEROCHOL® Data at EAS 2026 Meeting
LIB Therapeutics Highlights New Clinical Findings on LEROCHOL Presented at the 2026 European Atherosclerosis Society Congress in Athens LIB Therapeutics has reported new long-term clinical data for LEROCHOL® (lerodalcibep-liga), its…
Agilent Technologies Introduces Multi-Attribute Method (MAM) Solution to Advance Biopharma Quality Control
Agilent Technologies Introduces Advanced Multi-Attribute Method Solution to Streamline BioPharma Quality Control and Analytical Testing Agilent Technologies has announced the launch of a new multi-attribute method (MAM) workflow designed to…
Aphios Corporation Secures Patent Allowance for Novel Bryoid Composition Targeting Alzheimer’s, Multiple Sclerosis, HIV and Cancer
Aphios Corporation Receives Patent Allowance for Innovative Bryoid Composition Platform Aimed at Alzheimer’s, Multiple Sclerosis, HIV Reservoirs, and Oncology Applications Aphios Corporation has announced that the United States Patent and…
Curi Bio Unveils Curiverse™ at MPS 2026 for Scalable Human-Relevant Drug Discovery
Curi Bio Unveils Curiverse™ at MPS 2026, the First Closed-Loop Platform for Human-Relevant Drug Discovery Curi Bio has officially unveiled the Curiverse™ at the Microphysiological Systems World Summit 2026, introducing…
BreezeBio Establishes Scientific Advisory Board to Advance Precision Genetic Medicine Pipeline
BreezeBio Establishes Scientific Advisory Board to Advance Precision Genetic Medicine Pipeline BreezeBio, formerly known as GenEdit, has announced the formation of its inaugural Scientific Advisory Board (SAB), marking a significant…
Verastem Oncology Names Michael P. Bailey to Board of Directors
Verastem Oncology Names Michael P. Bailey to Board of Directors Verastem Oncology has announced the appointment of veteran biotechnology executive Michael P. Bailey to its Board of Directors, strengthening the…
SAGA Diagnostics Highlights NeoCircle Study on ctDNA Dynamics in Early Breast Cancer
SAGA Diagnostics Highlights NeoCircle Publication Showcasing Prognostic Impact of ctDNA Dynamics in Early Breast Cancer SAGA Diagnostics has announced the publication of new clinical research highlighting the potential of ultrasensitive…
IDEXX Laboratories Expands Fecal Dx Testing Platform with New Taeniid Tapeworm Detection Capability
IDEXX Enhances Fecal Dx™ Antigen Testing Platform with Advanced Taeniid Tapeworm Detection Capability IDEXX Laboratories has announced a significant expansion of its widely used Fecal Dx™ antigen testing platform, introducing…
TFG-001 Cell Therapy Demonstrates Improved Functional Recovery for Parkinson’s Disease
TFG-001 Shows Enhanced Neural Function and Reinnervation Potential in Parkinson’s Disease Cell Therapy Research TreeFrog Therapeutics has announced new preclinical findings for its investigational Parkinson’s disease cell therapy candidate, TFG-001,…
BeOne Medicines Showcases Oncology Leadership at ASCO and EHA 2026 with More Than 60 Abstracts
BeOne Medicines Showcases More Than 60 Abstracts at ASCO and EHA 2026 BeOne Medicines announced that it will present more than 60 scientific abstracts at two of the world’s most…